George Molina, MD, MPH, Awarded a $338K National Institutes of Health Grant

George Molina, MD, MPH, has been awarded a $338K grant from the National Institutes of Health National Center for Advancing Translational Sciences (NCATS) for the study, “Identifying factors associated with variation in surgical treatment of colorectal liver metastasis.”

The study’s main goal is to identify factors associated with variation in surgical treatment of colorectal liver metastasis, locally and nationally.

George Molina, MD, MPH
Associate Surgeon, Division of Surgical Oncology, Department of Surgery
Assistant Professor of Surgery, Harvard Medical School

Dr. Molina graduated from Johns Hopkins University with a BS in cellular and molecular biology. He obtained his medical degree from Harvard Medical School, and he completed an MPH in quantitative methods at Harvard T.H. Chan School of Public Health. He completed his general surgery residency at Massachusetts General Hospital and a fellowship in complex surgical oncology at Dana-Farber/Brigham and Women’s Hospital Cancer Center and Massachusetts General Hospital.

As part of his general surgery training, Dr. Molina also completed a two-year postgraduate research fellowship at Ariadne Labs, where he worked on projects in health systems innovation and research, global surgery modeling, clinical studies in surgical oncology, surgical safety culture in inpatient and ambulatory settings and impact of a surgical safety checklist program.

He is board certified in general surgery, and he is a member of the American College of Surgeons (ACS), the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO).

Dr. Molina’s clinical and research interests include improving the safety, quality and equity of surgical care through health systems innovation. He is also interested in understanding the impact of fragmentation of cancer care on disparities in surgical outcomes in the United States. Dr. Molina will be conducting his research at the Center for Surgery and Public Health and at Ariadne Labs.